205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
6.10%
Net income growth under 50% of QRVO's 63.82%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-1.69%
Negative yoy D&A while QRVO is 1.23%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-5800.00%
Negative yoy deferred tax while QRVO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
7.69%
SBC growth well above QRVO's 4.08%. Michael Burry would flag major dilution risk vs. competitor’s approach.
46.99%
Well above QRVO's 10.69% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
74.03%
AR growth well above QRVO's 27.10%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
31.67%
Inventory growth well above QRVO's 5.40%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
68.52%
AP growth of 68.52% while QRVO is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-12.90%
Both reduce yoy usage, with QRVO at -106.42%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
471.43%
Some yoy increase while QRVO is negative at -26.15%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
34.65%
Operating cash flow growth at 50-75% of QRVO's 61.88%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-1.63%
Both yoy lines negative, with QRVO at -97.54%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-174.33%
Negative yoy purchasing while QRVO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
39.84%
Liquidation growth of 39.84% while QRVO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-11600.00%
Both yoy lines negative, with QRVO at -25.62%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-210.13%
Both yoy lines negative, with QRVO at -49.52%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-79.27%
Both yoy lines negative, with QRVO at -45.12%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
2.39%
Buyback growth of 2.39% while QRVO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.